Greenwich Street

PACS Group, Inc. Announces Closing of Its Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares from the Selling Stockholders

Retrieved on: 
Martedì, Aprile 16, 2024
Nursing, Health, Hospitals, Residential Building & Real Estate, Other Health, Commercial Building & Real Estate, Construction & Property, Goldman Sachs, Sale, Prospectus, Investment, Kitchen Party (girl group), Capital market, Greenwich Street, RBC Capital Markets, RBC, Madison Avenue, Floor, Oppenheimer Holdings, Entrepreneurship, J. P. Morgan, Family, PACS, Equity capital markets, Multimedia, Citigroup, Attention, KeyBank, Security (finance)

In addition, the underwriters have exercised their 30-day option to purchase an additional 3,214,284 shares of the Company’s common stock at the initial public offering price from the selling stockholders, less underwriting discounts and commissions.

Key Points: 
  • In addition, the underwriters have exercised their 30-day option to purchase an additional 3,214,284 shares of the Company’s common stock at the initial public offering price from the selling stockholders, less underwriting discounts and commissions.
  • PACS did not receive any proceeds from any sale of shares by the selling stockholders.
  • The Company’s common stock is listed on the New York Stock Exchange under the ticker symbol “PACS.”
    This press release features multimedia.
  • (Photo: NYSE Group, Inc.)
    Citigroup, J.P. Morgan and Truist Securities acted as lead book-running managers for the offering.

PACS Group, Inc. Announces Pricing of Its Upsized Initial Public Offering

Retrieved on: 
Giovedì, Aprile 11, 2024
Commercial Building & Real Estate, Construction & Property, Hospitals, Practice Management, Other Health, Managed Care, Health, General Health, Residential Building & Real Estate, Goldman Sachs, Sale, Prospectus, Kitchen Party (girl group), Capital market, Greenwich Street, RBC Capital Markets, RBC, Truist, Madison Avenue, Oppenheimer Holdings, J. P. Morgan, PACS, Equity capital markets, Citigroup, Attention, KeyBank, Security (finance)

PACS Group, Inc. (“PACS” or the “Company”) today announced the pricing of its upsized initial public offering of 21,428,572 shares of its common stock being sold by the Company at a public offering price of $21.00 per share, for total gross proceeds of approximately $450 million, before deducting underwriting discounts and commissions and offering expenses.

Key Points: 
  • PACS Group, Inc. (“PACS” or the “Company”) today announced the pricing of its upsized initial public offering of 21,428,572 shares of its common stock being sold by the Company at a public offering price of $21.00 per share, for total gross proceeds of approximately $450 million, before deducting underwriting discounts and commissions and offering expenses.
  • In addition, certain selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 3,214,284 shares of the Company’s common stock at the initial public offering price, less underwriting discounts and commissions.
  • PACS will not receive any proceeds from any sale of shares by the selling stockholders.
  • Citigroup, J.P. Morgan and Truist Securities are acting as lead book-running managers for the offering.

Lazard Announces Total Consideration for Lazard Group LLC’s Cash Tender Offer for Its 3.750% Senior Notes Due 2025

Retrieved on: 
Martedì, Marzo 12, 2024
Finance, Consulting, Banking, Professional Services, Asset Management, Settlement date, Letter, Telephone, Tender offer, Note, Interest, Tender, Greenwich Street, Security (finance)

Per $1,000 principal amount of Notes validly tendered and not validly withdrawn pursuant to the Tender Offer.

Key Points: 
  • Per $1,000 principal amount of Notes validly tendered and not validly withdrawn pursuant to the Tender Offer.
  • Interest will cease to accrue on the Settlement Date for all Notes accepted for purchase in the Tender Offer, including any such Notes tendered through guaranteed delivery procedures.
  • The closing of the Tender Offer is subject to the satisfaction or waiver of certain conditions as set forth in the Offer to Purchase.
  • Holders must make their own decision as to whether to tender any of their Notes and, if so, the principal amount of their Notes to tender.

BNY Mellon 2024 Annual Meeting of Stockholders

Retrieved on: 
Martedì, Marzo 26, 2024
Greenwich Street, Shareholder, International, Webcast, BNY Mellon, Person, Annual general meeting

NEW YORK, March 26, 2024 /PRNewswire/ -- BNY Mellon (NYSE: BK) will hold the 2024 Annual Meeting of Stockholders at 240 Greenwich Street, New York, New York 10286 on Tuesday, April 9, 2024, at 9:00 a.m.

Key Points: 
  • NEW YORK, March 26, 2024 /PRNewswire/ -- BNY Mellon (NYSE: BK) will hold the 2024 Annual Meeting of Stockholders at 240 Greenwich Street, New York, New York 10286 on Tuesday, April 9, 2024, at 9:00 a.m.
  • The Notice of Annual Meeting and Proxy Statement was made available on February 29, 2024.
  • For more information on registration, see Annual Meeting Q&A in the 2024 Proxy Statement.
  • BNY Mellon will provide a live audio webcast of the Annual Meeting.

PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market

Retrieved on: 
Lunedì, Marzo 11, 2024
Attention, ADS, Greenwich Street, Bank, Depositary, Sale, American depositary receipt, BIC, Therapy, Security (finance), Settlement, Infection, BNY Mellon, DTC

Lyon (France) and Cambridge (MA, US), March 11, 2024, at 07:00am CET – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections, today announces that the Company’s voluntary delisting of American Depositary Shares (“ADSs”) representing its ordinary shares from The Nasdaq Capital Market (“Nasdaq”) has become effective.

Key Points: 
  • Lyon (France) and Cambridge (MA, US), March 11, 2024, at 07:00am CET – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections, today announces that the Company’s voluntary delisting of American Depositary Shares (“ADSs”) representing its ordinary shares from The Nasdaq Capital Market (“Nasdaq”) has become effective.
  • The Bank of New York Mellon serves as depositary (the “Depositary”) for the Company’s ADS facility.
  • On or about May 28, 2024, the Depositary may elect to sell the underlying ordinary shares.
  • Investors will receive either the underlying ordinary shares (if those have not yet been sold by the Depositary) or the cash received by the Depositary received upon sale of underlying ordinary shares, net of fees, if those underlying ordinary shares were sold.

PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market

Retrieved on: 
Martedì, Febbraio 20, 2024
Attention, ADS, Greenwich Street, Bank, Depositary, Sale, American depositary receipt, BIC, Therapy, Settlement, Infection, BNY Mellon, Euronext Paris, DTC, Security (finance)

The Company listed the ADSs on The Nasdaq Global Select Market in November 2017 under the ticker ERYP, and subsequently transferred the listing of its ADSs to The Nasdaq Capital Market in April 2023.

Key Points: 
  • The Company listed the ADSs on The Nasdaq Global Select Market in November 2017 under the ticker ERYP, and subsequently transferred the listing of its ADSs to The Nasdaq Capital Market in April 2023.
  • “Given PHAXIAM’s current stage of development, we have determined that delisting from the Nasdaq market was the wisest business and financial decision for the company.
  • PHAXIAM Therapeutics remains listed on Euronext Paris as its primary trading market and intends to continue its disclosures in compliance with applicable French financial market regulations.
  • Investors will receive either the underlying ordinary shares (if those have not yet been sold by the Depositary) or the cash received by the Depositary received upon sale of underlying ordinary shares, net of fees, if those underlying ordinary shares were sold.

Lazard Announces Commencement of Senior Notes Offering and Concurrent Tender Offer by Lazard Group LLC

Retrieved on: 
Mercoledì, Marzo 6, 2024
Professional Services, Finance, Letter, Prospectus, Telephone, Greenwich Street, Sale, Debt-to-GDP ratio, Information, Tender offer, Broadridge Financial Solutions, Security (finance), LAZ, Tender, Offering

Lazard, Inc. (NYSE: LAZ) announced today that its subsidiary Lazard Group LLC (“Lazard Group”) is commencing an offering (the “Offering”) of one or more series of its senior notes (the “Notes”).

Key Points: 
  • Lazard, Inc. (NYSE: LAZ) announced today that its subsidiary Lazard Group LLC (“Lazard Group”) is commencing an offering (the “Offering”) of one or more series of its senior notes (the “Notes”).
  • The Notes would be senior unsecured obligations of Lazard Group.
  • Concurrently with the Offering, Lazard Group is commencing a cash tender offer (the “Tender Offer”) for any and all of its outstanding 3.750% Senior Notes due February 13, 2025 (the “2025 Notes”).
  • Citigroup Global Markets Inc. and Lazard Frères & Co. LLC are acting as joint lead book-running managers and joint lead managers for the Offering.

Lazard Announces Cash Tender Offer for 3.750% Senior Notes Due 2025 of Lazard Group LLC

Retrieved on: 
Mercoledì, Marzo 6, 2024
Banking, Professional Services, Finance, Letter, Note, Telephone, Greenwich Street, Settlement date, ATTN:, Tender offer, Interest, Tender, Security (finance)

Interest will cease to accrue on the Settlement Date for all Notes accepted for purchase in the Tender Offer, including any such Notes tendered through guaranteed delivery procedures.

Key Points: 
  • Interest will cease to accrue on the Settlement Date for all Notes accepted for purchase in the Tender Offer, including any such Notes tendered through guaranteed delivery procedures.
  • Citigroup Global Markets Inc. is acting as the lead dealer manager and Lazard Frères & Co. LLC is acting as co-dealer manager (together, the “Dealer Managers”) for the Tender Offer.
  • None of Lazard Group or its affiliates, their respective boards of directors, the Dealer Managers, the Tender Agent, the Information Agent or the trustee for the Notes makes any recommendation as to whether holders should tender any of their Notes.
  • Holders must make their own decision as to whether to tender any of their Notes and, if so, the principal amount of their Notes to tender.

Thor Equities Group Announces Long Term Lease with The Pilecki Institute at 88 Greenwich Street

Retrieved on: 
Lunedì, Febbraio 5, 2024
Thor, Research, National heritage, History, Greenwich Street, Pilecki Institute, Ministry, Coffee, EVP, Documentation, 88 Greenwich Street, Sale, Republic

New York, NY, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Thor Equities Group, a global leader in real estate development, leasing, and management, is pleased to announce a long-term lease with The Pilecki Institute, for 35,000 square feet at 88 Greenwich Street in Downtown Manhattan, marking the Institute’s first location outside of Europe.

Key Points: 
  • New York, NY, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Thor Equities Group, a global leader in real estate development, leasing, and management, is pleased to announce a long-term lease with The Pilecki Institute, for 35,000 square feet at 88 Greenwich Street in Downtown Manhattan, marking the Institute’s first location outside of Europe.
  • The Pilecki Institute, a research and cultural institution founded in 2016, works to preserve the remembrance, documentation, and research of the historical experiences of Polish citizens, while increasing awareness regarding totalitarianism in the 20th century.
  • “The Pilecki Institute’s decision to open at 88 Greenwich is a testament to the building’s excellent location and underscores the importance of having a presence in the New York City market,” Chief Operating Officer of Thor Equities Group, Melissa Gliatta.
  • “We are pleased to welcome them to their new home and support their important mission.”
    Regular Coffee has also signed a long term lease at 88 Greenwich Street and is planning to open early this year in a 1,500 square feet space.

Nano Labs Announced Updates to Holders of ADRs Regarding Amendment to the Deposit Agreement and Termination of ADR Facility

Retrieved on: 
Mercoledì, Gennaio 3, 2024
Transfer, ADS, Finance Secretary (India), Share, American depositary receipt, Form, File, Citibank, ADR, Deposit, Greenwich Street, Security (finance)

1 to the Deposit Agreement, and (y) a form of ADR that reflects the additional termination provision with the U.S. Securities and Exchange Commission (the "SEC") under cover of Post-Effective Amendment No.

Key Points: 
  • 1 to the Deposit Agreement, and (y) a form of ADR that reflects the additional termination provision with the U.S. Securities and Exchange Commission (the "SEC") under cover of Post-Effective Amendment No.
  • HEREBY GIVES NOTICE OF THE TERMINATION OF THE AMERICAN DEPOSITARY RECEIPTS FACILITY FOR THE ADSs EFFECTIVE AS OF THE TERMINATION DATE.
  • After effectuating the Mandatory Exchange, the Depositary shall be discharged from all obligations under the Deposit Agreement with respect to the ADRs, the Deposited Securities and the ADSs under the Deposit Agreement.
  • If you have any questions about the above termination and Mandatory Exchange, please call Citibank ADR Shareholder Services at 1-877-248-4237.